High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era

The impact of rituximab on outcome of high dose therapy and autologous stem cell transplantation (HD-ASCT) for transformed NHL has not been previously described. We analyzed eighteen consecutive patients with indolent NHL who transformed to diffuse large B-cell lymphoma (DLBCL), received rituximab-c...

Full description

Saved in:
Bibliographic Details
Main Authors: Ban-Hoefen, Makiko, Kelly, Jennifer L., Bernstein, Steven H., Liesveld, Jane, Constine, Louis, Becker, Michael, Milner, Laurie, Phillips, Gordon, Friedberg, Jonathan W.
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3653616/
https://ncbi.nlm.nih.gov/pubmed/22023518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.631637
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items